Nomura Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $98.8M | Sell |
782,267
-45,906
| -6% | -$6.05M | 0.21% | 88 |
|
|
2026
Q1 | $115M | Sell |
828,173
-14,010
| -2% | -$1.96M | 0.3% | 60 |
|
|
2025
Q4 | $103M | Buy |
842,183
+4,598
| +0.5% | +$559K | 0.26% | 68 |
|
|
2025
Q3 | $93M | Buy |
837,585
+52,910
| +7% | +$6.01M | 0.24% | 77 |
|
|
2025
Q2 | $87M | Sell |
784,675
-91,847
| -10% | -$9.77M | 0.24% | 88 |
|
|
2025
Q1 | $98.2M | Buy |
876,522
+12,959
| +2% | +$1.34M | 0.3% | 71 |
|
|
2024
Q4 | $79.8M | Sell |
863,563
-3,407
| -0.4% | -$307K | 0.24% | 85 |
|
|
2024
Q3 | $72.7M | Sell |
866,970
-97,655
| -10% | -$7.45M | 0.22% | 99 |
|
|
2024
Q2 | $66.2M | Buy |
964,625
+59,774
| +7% | +$3.99M | 0.23% | 92 |
|
|
2024
Q1 | $66.3M | Sell |
904,851
-1,819
| -0.2% | -$140K | 0.24% | 91 |
|
|
2023
Q4 | $73.4M | Buy |
906,670
+14,557
| +2% | +$1.13M | 0.3% | 74 |
|
|
2023
Q3 | $66.9M | Buy |
892,113
+31,032
| +4% | +$2.39M | 0.31% | 68 |
|
|
2023
Q2 | $66.4M | Buy |
861,081
+122,270
| +17% | +$9.75M | 0.31% | 68 |
|
|
2023
Q1 | $61.3M | Buy |
738,811
+49,701
| +7% | +$4.12M | 0.32% | 69 |
|
|
2022
Q4 | $59.2M | Sell |
689,110
-88,068
| -11% | -$6.97M | 0.34% | 63 |
|
|
2022
Q3 | $47.9M | Buy |
777,178
+24,032
| +3% | +$1.52M | 0.31% | 73 |
|
|
2022
Q2 | $46.6M | Sell |
753,146
-28,520
| -4% | -$1.77M | 0.29% | 79 |
|
|
2022
Q1 | $46.5M | Buy |
781,666
+66,653
| +9% | +$4.26M | 0.25% | 89 |
|
|
2021
Q4 | $51.9M | Sell |
715,013
-188,800
| -21% | -$13M | 0.26% | 91 |
|
|
2021
Q3 | $63.1M | Buy |
903,813
+171,110
| +23% | +$12M | 0.36% | 69 |
|
|
2021
Q2 | $50.5M | Sell |
732,703
-9,924
| -1% | -$663K | 0.29% | 84 |
|
|
2021
Q1 | $48M | Sell |
742,627
-3,203
| -0.4% | -$207K | 0.31% | 83 |
|
|
2020
Q4 | $43.5M | Buy |
745,830
+201,921
| +37% | +$12.2M | 0.29% | 80 |
|
|
2020
Q3 | $34.4M | Buy |
543,909
+117,485
| +28% | +$8.15M | 0.26% | 89 |
|
|
2020
Q2 | $32.8M | Sell |
426,424
-38,545
| -8% | -$2.95M | 0.28% | 80 |
|
|
2020
Q1 | $34.8M | Sell |
464,969
-108,182
| -19% | -$7.48M | 0.36% | 70 |
|
|
2019
Q4 | $37.2M | Buy |
573,151
+1,904
| +0.3% | +$124K | 0.33% | 70 |
|
|
2019
Q3 | $36.2M | Buy |
571,247
+23,419
| +4% | +$1.53M | 0.35% | 69 |
|
|
2019
Q2 | $37M | Sell |
547,828
-9,519
| -2% | -$626K | 0.37% | 68 |
|
|
2019
Q1 | $36.2M | Buy |
557,347
+53,172
| +11% | +$3.53M | 0.36% | 71 |
|
|
2018
Q4 | $31.5M | Buy |
504,175
+79,286
| +19% | +$5.54M | 0.35% | 70 |
|
|
2018
Q3 | $32.8M | Sell |
424,889
-14,267
| -3% | -$1.08M | 0.32% | 75 |
|
|
2018
Q2 | $31.1M | Sell |
439,156
-282,705
| -39% | -$20M | 0.32% | 69 |
|
|
2018
Q1 | $54.4M | Sell |
721,861
-98,170
| -12% | -$7.8M | 0.59% | 38 |
|
|
2017
Q4 | $58.7M | Sell |
820,031
-1,029
| -0.1% | -$78.1K | 0.68% | 34 |
|
|
2017
Q3 | $66.5M | Buy |
821,060
+352,683
| +75% | +$27M | 0.86% | 25 |
|
|
2017
Q2 | $33.2M | Sell |
468,377
-7,437
| -2% | -$495K | 0.45% | 56 |
|
|
2017
Q1 | $32.3M | Sell |
475,814
-92,748
| -16% | -$6.52M | 0.46% | 56 |
|
|
2016
Q4 | $40.8M | Buy |
568,562
+32,395
| +6% | +$2.41M | 0.74% | 21 |
|
|
2016
Q3 | $42.4M | Buy |
536,167
+36,743
| +7% | +$2.98M | 0.76% | 24 |
|
|
2016
Q2 | $41.7M | Buy |
499,424
+1,486
| +0.3% | +$132K | 0.78% | 24 |
|
|
2016
Q1 | $45.7M | Buy |
497,938
+96,182
| +24% | +$8.67M | 0.87% | 16 |
|
|
2015
Q4 | $40.7M | Sell |
401,756
-5,357
| -1% | -$557K | 0.79% | 22 |
|
|
2015
Q3 | $40M | Buy |
407,113
+12,014
| +3% | +$1.33M | 0.8% | 21 |
|
|
2015
Q2 | $46.3M | Sell |
395,099
-4,401
| -1% | -$481K | 0.86% | 16 |
|
|
2015
Q1 | $39.2M | Sell |
399,500
-19,928
| -5% | -$2.02M | 0.7% | 31 |
|
|
2014
Q4 | $40M | Sell |
419,428
-20,229
| -5% | -$2.09M | 0.7% | 27 |
|
|
2014
Q3 | $46.5M | Sell |
439,657
-51,773
| -11% | -$5.07M | 0.82% | 22 |
|
|
2014
Q2 | $41M | Buy |
491,430
+258,114
| +111% | +$20.1M | 0.76% | 24 |
|
|
2014
Q1 | $16.5M | Buy |
233,316
+10,079
| +5% | +$790K | 0.3% | 89 |
|
|
2013
Q4 | $16.8M | Sell |
223,237
-27,443
| -11% | -$1.91M | 0.3% | 99 |
|
|
2013
Q3 | $15.8M | Buy |
250,680
+4,630
| +2% | +$277K | 0.3% | 88 |
|
|
2013
Q2 | $12.6M | Buy |
+246,050
| New | +$12.8M | 0.25% | 93 |
|
Other funds holding GILD
Nomura Asset Management's GILD Position: Q2 2026 in Review
Nomura Asset Management reduced its Gilead Sciences (GILD) stake by 5.5% in Q2 2026, selling an estimated $6.05M and leaving 782,267 shares worth $98.8M. The position accounts for 0.21% of the portfolio, ranked #88.
Nomura Asset Management first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $115M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Nomura Asset Management held 782,267 shares of Gilead Sciences worth $98.8M as of Q2 2026.
- Nomura Asset Management sold 45,906 Gilead Sciences shares in Q2 2026, an estimated $6.05M.
- Gilead Sciences made up 0.21% of Nomura Asset Management's portfolio in Q2 2026, its #88 holding.
- Nomura Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Nomura Asset Management's Gilead Sciences position peaked at $115M in Q1 2026.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Nomura Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.